SIEMENS HEALTH ADR/050 Total Liabilities

Latest as of December 2025: €25.79 Billion EUR ≈ $30.15 Billion USD

SIEMENS HEALTH ADR/050 total liabilities. Based on the latest financial reports, SIEMENS HEALTH ADR/050 (SHL1) has total liabilities worth €25.79 Billion EUR (≈ $30.15 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See defensive interval ratio of SIEMENS HEALTH ADR/050 to measure how many days the company can operate on defensive assets alone.

Total Liabilities of SIEMENS HEALTH ADR/050 (2022–2024)

Total liabilities of SIEMENS HEALTH ADR/050 from 2022 to 2024. This chart illustrates how SIEMENS HEALTH ADR/050's total liabilities have evolved over time, based on quarterly financial data. Check SIEMENS HEALTH ADR/050 liquid asset ratio to evaluate the company's liquid asset resilience ratio.

SIEMENS HEALTH ADR/050 Competitors by Total Liabilities

The table below lists competitors of SIEMENS HEALTH ADR/050 ranked by their total liabilities.

Company Country Total Liabilities
Swedbank AB (publ)
ST:SWED-A
Sweden Skr3.10 Trillion
Vistra Energy Corp
NYSE:VST
USA $32.80 Billion
Polski Koncern Naftowy ORLEN SA
WAR:PKN
Poland zł120.50 Billion
Waste Connections Inc
TO:WCN
Canada CA$13.46 Billion
Samsung Biologics Co Ltd
KO:207940
Korea ₩4.29 Trillion
State Street Corp
NYSE:STT
USA $390.11 Billion
Nike Inc
NYSE:NKE
USA $22.97 Billion
Hangzhou Hikvision Digital Technology Co Ltd
SHE:002415
China CN¥44.56 Billion

Liability Composition Analysis (2022–2024)

This chart breaks down SIEMENS HEALTH ADR/050's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see SHL1 total assets.

Liquidity & Leverage Metrics

SIEMENS HEALTH ADR/050 Total Liabilities Ratios Explained

SIEMENS HEALTH ADR/050 total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.04 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.40 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.58 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how SIEMENS HEALTH ADR/050's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for SIEMENS HEALTH ADR/050 (2022–2024)

The table below shows the annual total liabilities of SIEMENS HEALTH ADR/050 from 2022 to 2024.

Year Total Liabilities Change
2024-09-30 €27.81 Billion
≈ $32.51 Billion
-2.61%
2023-09-30 €28.55 Billion
≈ $33.38 Billion
-2.24%
2022-09-30 €29.20 Billion
≈ $34.14 Billion
--

About SIEMENS HEALTH ADR/050

F:SHL1 Germany Medical Devices
Market Cap
$46.68 Billion
€39.93 Billion EUR
Market Cap Rank
#573 Global
#117 in Germany
Share Price
€17.80
Change (1 day)
-4.81%
52-Week Range
€17.40 - €24.80
All Time High
€31.69
About

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound sys… Read more